ADAGE CAPITAL PARTNERS GP, L.L.C. - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2014$65,473,000
+47.1%
1,443,400
+34.3%
0.16%
+40.9%
Q2 2014$44,516,000
-4.8%
1,075,000
+59.3%
0.12%
-10.2%
Q1 2014$46,757,000
+49.4%
675,000
+30.0%
0.13%
+54.2%
Q4 2013$31,302,000519,3650.08%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2013
NameSharesValueWeighting ↓
Versant Venture Management, LLC 407,416$14,259,560,0008.34%
Palo Alto Investors LP 3,547,719$124,170,0006.91%
Antipodean Advisors LLC 1,268,658$44,403,0006.48%
Redmile Group, LLC 1,795,936$62,858,0004.70%
HealthCor Management, L.P. 1,525,000$53,375,0003.24%
PointState Capital LP 3,503,900$122,637,0003.12%
NEA Management Company, LLC 1,139,890$39,896,0002.54%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 612,500$21,438,0002.44%
PFM Health Sciences, LP 2,078,440$72,745,0002.21%
Partner Investment Management, L.P. 35,300$1,236,0002.03%
View complete list of CLOVIS ONCOLOGY INC shareholders